Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acidic anionic endosomal membranes are specialized lipid bilayers that define the compartments of the endocytic pathway, specifically late endosomes and lysosomes. They are characterized by an acidic internal pH (typically 5.0–6.0) maintained by V-ATPase proton pumps and a unique lipid composition enriched with anionic lipids such as bis(monoacylglycero)phosphate (BMP), also known as lysobisphosphatidic acid [Huotari, J. & Helenius, A. (2011). EMBO J]. These membranes play a pivotal role in cellular homeostasis by regulating the sorting, trafficking, and degradation of internalized cargo. In pharmacology, they are a primary target for advanced drug delivery systems like lipid nanoparticles (LNPs) and cell-penetrating peptides, which utilize the acidic environment to trigger endosomal escape and deliver therapeutic payloads into the cytoplasm [Cullis, P. R. & Hope, M. J. (2017). Mol Ther]. Furthermore, many viruses exploit the low pH and specific lipid signatures of these membranes to undergo fusion and enter host cells, making them a critical focus for antiviral therapeutic strategies [Gruenberg, J. (2020). FEBS Lett].
Interaction with acidic anionic endosomal membranes typically involves pH-dependent protonation of ionizable groups on the drug or delivery vehicle, which promotes electrostatic interaction with anionic lipids like bis(monoacylglycero)phosphate (BMP). This leads to membrane fusion or disruption (e.g., the proton sponge effect), facilitating the translocation of therapeutic cargo into the cytosol. Alternatively, pharmacological agents may inhibit V-ATPase to prevent acidification, thereby blocking viral entry or protein degradation [Cullis, P. R. & Hope, M. J. (2017). Mol Ther; Savarino, A., et al. (2003). Lancet Infect Dis].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acidic anionic endosomal membranes.